Immunotherapy and Prognosis of Non-small Cell Lung Carcinoma by Monomethoxy polyethylene glycol-hyaluronic acid-platinum Combined with Immune CT4+ and CT8+ Detection.

Ren, Xubin; Luo, Tong; Ma, Hailong; Zhou, Meili; Yu, Shufang

Ren, Xubin; Luo, Tong; Ma, Hailong; Zhou, Meili; Yu, Shufang.

Affiliation

Ren X; Department of Respiratory and Critical Care Medicine, Chengdu First People's Hospital, Chengdu, 610095, Sichuan, China. yushufang2022@yandex.com.
Luo T; Department of Pediatrics, Chengdu BOE Hospital, Chengdu, 610200, Sichuan, China. yushufang2022@yandex.com.
Ma H; Emergency Center, Affiliated Qingdao Central Hospital, Qingdao University, Qingdao, 266042,Shandong, China. yushufang2022@yandex.com.
Zhou M; Emergency Center, Affiliated Qingdao Central Hospital, Qingdao University, Qingdao, 266042,Shandong, China. yushufang2022@yandex.com.
Yu S; Zhejiang Pharmaceutical College, Fenghua District, Ningbo, 315100, Zhejiang, China. yushufang2022@yandex.com.

Cell Mol Biol (Noisy-le-grand) ; 68(6): 167-173, 2022 Jun 30.

Article in En | MEDLINE | ID: mdl-36227659

Subject(s)

Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung/drug therapy; Humans; Hyaluronic Acid/therapeutic use; Immunotherapy; Lung Neoplasms/drug therapy; Platinum/therapeutic use; Polyethylene Glycols/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Cell Mol Biol (Noisy-le-grand) Journal subject: BIOLOGIA MOLECULAR Year: 2022 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google